Recombinant Human Anti-Insulin precursor Soluble TCR (1.2) (C-Cys) (CAT#: VS-0622-YF3933)
Human TCR (1.2) recognizes Insulin precursor peptide (AGSLQPLAL) in the context of HLA-DQ8. Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.
Specific Inquiry
Specifications
- Host Species
- Human
- Target
- Insulin precursor
- Species Reactivity
- Human
- Epitope
- AGSLQPLAL
- MHC
- HLA-DQ8
- Clone
- 1.2
- Type
- Soluble TCR (C-Cys)
- Related Disease
- Others
- TCR Expression Strategy
- C-Cys strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on C-terminal Cys. The soluble TCR contains variable regions and partial constant regions.
Target
- Alternative Names
- Hypothetical Protein
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone 1.2"
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0622-YF3933. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, Neut, IF, IP, FC, FuncS
Application: ELISA, Neut, IF, IP, FC, FuncS
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application: WB, Neut, FuncS
Application: WB, ELISA, FuncS
Application: WB, IHC, ELISA, FC
Application: ELISA, Inhib, FuncS
Application: IF, IP, Neut, FuncS, ELISA, FC
Application: ELISA, IHC, WB
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
